A randomized trial of nebulized 3% hypertonic saline with salbutamol in the treatment of acute bronchiolitis in hospitalized infants - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1002/ppul.23306. Epub 2015 Sep 3.
Affiliations
- PMID: 26334188
- DOI: 10.1002/ppul.23306
Randomized Controlled Trial
A randomized trial of nebulized 3% hypertonic saline with salbutamol in the treatment of acute bronchiolitis in hospitalized infants
Pedro Flores et al. Pediatr Pulmonol. 2016 Apr.
Abstract
Objective: Acute bronchiolitis is a common disorder of infants that often results in hospitalization. Apart from supportive care, no therapy has been shown to influence the course of the disease, except for a possible effect of nebulized hypertonic saline (HS). To determine whether this does have beneficial effects on length of stay in hospital or on severity scores, we undertook a double-blind, randomized, controlled trial in a pediatric department of a Portuguese hospital.
Methods: Previously healthy infants, younger than 12 months, hospitalized with mild-to-moderate acute viral bronchiolitis were randomized to receive either nebulized 3% (hypertonic, HS) or 0.9% (normal, NS) saline during their entire hospital stay. Primary endpoints were: length of hospital stay and severity scores on each day of hospitalization. Need for supplemental oxygen, further add-on medications and adverse effects were also analyzed.
Results: Sixty-eight patients completed the study (HS: 33; NS: 35). The median length of hospital stay did not differ between groups: HS: 5.6 ± 2.3 days; NS: 5.4 ± 2.1 days (P = 0.747). We found no difference between groups in severity scores from day 1 to day 4. There were no differences in need for supplemental oxygen or add-on medications. Patients in HS group had significantly more cough (46% vs. 20%, P = 0.025) and rhinorrhoe (58% vs. 31%, P = 0.30).
Conclusion: This study does not support the use of nebulized HS over NS in therapy of hospitalized children with mild-to-moderate acute viral bronchiolitis.
Keywords: Pneumonia; TB; asthma & early wheeze; evidence-based medicine & outcomes; viral.
© 2015 Wiley Periodicals, Inc.
Similar articles
- Effect of Nebulized Hypertonic Saline Treatment in Emergency Departments on the Hospitalization Rate for Acute Bronchiolitis: A Randomized Clinical Trial.
Angoulvant F, Bellêttre X, Milcent K, Teglas JP, Claudet I, Le Guen CG, de Pontual L, Minodier P, Dubos F, Brouard J, Soussan-Banini V, Degas-Bussiere V, Gatin A, Schweitzer C, Epaud R, Ryckewaert A, Cros P, Marot Y, Flahaut P, Saunier P, Babe P, Patteau G, Delebarre M, Titomanlio L, Vrignaud B, Trieu TV, Tahir A, Regnard D, Micheau P, Charara O, Henry S, Ploin D, Panjo H, Vabret A, Bouyer J, Gajdos V; Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis (GUERANDE) Study Group. Angoulvant F, et al. JAMA Pediatr. 2017 Aug 7;171(8):e171333. doi: 10.1001/jamapediatrics.2017.1333. Epub 2017 Aug 7. JAMA Pediatr. 2017. PMID: 28586918 Free PMC article. Clinical Trial. - Does nebulized hypertonic saline shorten hospitalization in young children with acute viral wheezing?
Kanjanapradap T, Deerojanawong J, Sritippayawan S, Prapphal N. Kanjanapradap T, et al. Pediatr Pulmonol. 2018 Feb;53(2):138-144. doi: 10.1002/ppul.23924. Epub 2017 Dec 21. Pediatr Pulmonol. 2018. PMID: 29266863 Clinical Trial. - The efficacy of nebulized salbutamol, hypertonic saline and salbutamol/hypertonic saline combination in moderate bronchiolitis.
Ipek IO, Yalcin EU, Sezer RG, Bozaykut A. Ipek IO, et al. Pulm Pharmacol Ther. 2011 Dec;24(6):633-7. doi: 10.1016/j.pupt.2011.09.004. Epub 2011 Sep 29. Pulm Pharmacol Ther. 2011. PMID: 21978929 Clinical Trial. - [Nebulized hypertonic saline and acute viral bronchiolitis in infants: current aspects].
Sauvaget E, David M, Bresson V, Retornaz K, Bosdure E, Dubus JC. Sauvaget E, et al. Arch Pediatr. 2012 Jun;19(6):635-41. doi: 10.1016/j.arcped.2012.03.018. Epub 2012 Apr 30. Arch Pediatr. 2012. PMID: 22551894 Review. French. - Nebulized hypertonic saline solution for acute bronchiolitis in infants.
Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Zhang L, et al. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006458. doi: 10.1002/14651858.CD006458.pub2. Cochrane Database Syst Rev. 2008. PMID: 18843717 Updated. Review.
Cited by
- Comparison of nebulised 3% hypertonic saline with ipratropium bromide in treatment of children with bronchiolitis: a randomized control trial.
Naveed H, Munir S, Rafiq K, Tayyab A, Naseer N, Hussain I, Halim M, Mumtaz H. Naveed H, et al. Ann Med Surg (Lond). 2023 Sep 5;85(11):5484-5490. doi: 10.1097/MS9.0000000000001174. eCollection 2023 Nov. Ann Med Surg (Lond). 2023. PMID: 37915631 Free PMC article. - Efficacy of 3% hypertonic saline in bronchiolitis: A meta-analysis.
Wang ZY, Li XD, Sun AL, Fu XQ. Wang ZY, et al. Exp Ther Med. 2019 Aug;18(2):1338-1344. doi: 10.3892/etm.2019.7684. Epub 2019 Jun 18. Exp Ther Med. 2019. PMID: 31384334 Free PMC article. - Pediatric pulmonology year in review 2016: Part 2.
Auten R, Ren C, Yilmaz O, Noah TL. Auten R, et al. Pediatr Pulmonol. 2017 Sep;52(9):1219-1225. doi: 10.1002/ppul.23719. Epub 2017 Apr 25. Pediatr Pulmonol. 2017. PMID: 28440920 Free PMC article. Review. - The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis: a decision analysis.
Heikkilä P, Mecklin M, Korppi M. Heikkilä P, et al. World J Pediatr. 2018 Feb;14(1):26-34. doi: 10.1007/s12519-017-0112-8. Epub 2018 Feb 23. World J Pediatr. 2018. PMID: 29476325 Review. - Nebulised hypertonic saline solution for acute bronchiolitis in infants.
Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Zhang L, et al. Cochrane Database Syst Rev. 2017 Dec 21;12(12):CD006458. doi: 10.1002/14651858.CD006458.pub4. Cochrane Database Syst Rev. 2017. PMID: 29265171 Free PMC article. Updated. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous